Found 7 results
Author Keyword Title [ Type(Desc)] Year
Filters: Keyword is Non-alcoholic Fatty Liver Disease  [Clear All Filters]
Journal Article
Lytle KA, Depner CM, Wong CP, Jump DB.  2015.  Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.. J Lipid Res. 56(10):1936-46.
Lytle KA, Wong CP, Jump DB.  2017.  Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.. PLoS One. 12(4):e0173376.
Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.
Athinarayanan S, Wei R, Zhang M, Bai S, Traber MG, Yates K, Cummings OW, Molleston J, Liu W, Chalasani N.  2014.  Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.. PLoS One. 9(4):e95366.
Depner CM, Traber MG, Bobe G, Kensicki E, Bohren KM, Milne G, Jump DB.  2013.  A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.. PLoS One. 8(12):e83756.
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Lytle KA, Jump DB.  2016.  Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible? PLoS One. 11(1):e0146942.